Iluta S, Nistor M, Buruiana S, Dima D
Life (Basel). 2025; 15(2).
PMID: 40003637
PMC: 11856057.
DOI: 10.3390/life15020228.
Wireko A, Ben-Jaafar A, Kong J, Mannan K, Sanker V, Rosenke S
Mol Brain. 2024; 17(1):83.
PMID: 39568072
PMC: 11580395.
DOI: 10.1186/s13041-024-01155-w.
Wang X, Guo Y, Lin P, Yu M, Song S, Xu W
EMBO J. 2024; 43(24):6336-6363.
PMID: 39516282
PMC: 11649922.
DOI: 10.1038/s44318-024-00290-3.
Kamalakar A, Tobin B, Kaimari S, Robinson M, Toma A, Cha T
Elife. 2024; 13.
PMID: 39401071
PMC: 11473100.
DOI: 10.7554/eLife.92925.
Nose K, Taniguchi K, Fujita M, Moyama C, Mori M, Ishita M
Cancer Gene Ther. 2024; 31(12):1831-1839.
PMID: 39394529
DOI: 10.1038/s41417-024-00835-y.
Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies.
Agosti E, Antonietti S, Ius T, Fontanella M, Zeppieri M, Panciani P
Int J Mol Sci. 2024; 25(14.
PMID: 39063221
PMC: 11276876.
DOI: 10.3390/ijms25147979.
Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy.
Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H
Biomolecules. 2024; 14(4).
PMID: 38672496
PMC: 11048644.
DOI: 10.3390/biom14040480.
Novel insights into Notch signaling in tumor immunity: potential targets for cancer immunotherapy.
Wang M, Yu F, Zhang Y, Li P
Front Immunol. 2024; 15:1352484.
PMID: 38444855
PMC: 10912471.
DOI: 10.3389/fimmu.2024.1352484.
The Emerging Function and Promise of tRNA-Derived Small RNAs in Cancer.
Yang N, Li R, Liu R, Yang S, Zhao Y, Xiong W
J Cancer. 2024; 15(6):1642-1656.
PMID: 38370372
PMC: 10869971.
DOI: 10.7150/jca.89219.
Golgi-to-ER retrograde transport prevents premature differentiation of type II neuroblasts via Notch-signal-sending daughter cells.
Zhang H, Rui M, Ma Z, Gong S, Zhang S, Zhou Q
iScience. 2024; 27(1):108545.
PMID: 38213621
PMC: 10783626.
DOI: 10.1016/j.isci.2023.108545.
Study Deciphering the Crucial Involvement of Notch Signaling Pathway in Human Cancers.
Pandey P, Khan F, Singh M, Verma A, Kumar H, Mazumder A
Endocr Metab Immune Disord Drug Targets. 2023; 24(11):1241-1253.
PMID: 37997805
DOI: 10.2174/0118715303261691231107113548.
Delivery of A Jagged1-PEG-MAL hydrogel with Pediatric Human Bone Cells Regenerates Critically-Sized Craniofacial Bone Defects.
Kamalakar A, Tobin B, Kaimari S, Robinson M, Toma A, Cha T
bioRxiv. 2023; .
PMID: 37873448
PMC: 10592619.
DOI: 10.1101/2023.10.06.561291.
Zinc Finger 521 Modulates the Nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma.
Scicchitano S, Faniello M, Mesuraca M
Int J Mol Sci. 2023; 24(19).
PMID: 37834202
PMC: 10572470.
DOI: 10.3390/ijms241914755.
Jagged 1 Regulates The Proliferation and Metastasis of Human MDA-T68 Thyroid Cancer Cells.
Chen J, Wang X, Zhang X, Yin J, Zheng Y
Cell J. 2023; 25(6):399-406.
PMID: 37434457
PMC: 10331446.
DOI: 10.22074/cellj.2023.1989117.1222.
G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells.
Cao Y, Liu B, Cai L, Li Y, Huang Y, Zhou Y
CNS Neurosci Ther. 2023; 29(9):2508-2521.
PMID: 36971192
PMC: 10401078.
DOI: 10.1111/cns.14191.
Notch signaling, hypoxia, and cancer.
Guo M, Niu Y, Xie M, Liu X, Li X
Front Oncol. 2023; 13:1078768.
PMID: 36798826
PMC: 9927648.
DOI: 10.3389/fonc.2023.1078768.
The Role of Cellular Prion Protein in Glioma Tumorigenesis Could Be through the Autophagic Mechanisms: A Narrative Review.
Armocida D, Busceti C, Biagioni F, Fornai F, Frati A
Int J Mol Sci. 2023; 24(2).
PMID: 36674920
PMC: 9865539.
DOI: 10.3390/ijms24021405.
PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes and to Repress HNSCC Cell Proliferation.
Wu M, Lu R, Yu S, Tsai Y, Lin Y, Bai Z
Biomedicines. 2022; 10(11).
PMID: 36428516
PMC: 9687978.
DOI: 10.3390/biomedicines10112948.
Carbon Ion Irradiation Downregulates Notch Signaling in Glioma Cell Lines, Impacting Cell Migration and Spheroid Formation.
Kumar V, Vashishta M, Kong L, Lu J, Wu X, Dwarakanath B
Cells. 2022; 11(21).
PMID: 36359750
PMC: 9655483.
DOI: 10.3390/cells11213354.
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development.
You W, Schuetz T, Lee S
Mol Cancer Ther. 2022; 22(1):3-11.
PMID: 36223541
PMC: 9808372.
DOI: 10.1158/1535-7163.MCT-22-0243.